Shajia Lu

机构：National Institute of Arthritis and Musculoskeletal and Skin Diseases

发表论文 26 篇 · 总被引 861 次 · h-index 13

代表论文

• Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus (2021 · Nature Communications · 被引 200)
• Dominant Mutations in KBTBD13, a Member of the BTB/Kelch Family, Cause Nemaline Myopathy with Cores (2010 · The American Journal of Human Genetics · 被引 161)
• Janus kinase (JAK) inhibition with baricitinib in refractory juvenile dermatomyositis (2020 · Annals of the Rheumatic Diseases · 被引 93)
• New N-RAP-binding partners α-actinin, filamin and Krp1 detected by yeast two-hybrid screening: implications for myofibril assembly (2003 · Journal of Cell Science · 被引 60)
• Ultrastructural and Biochemical Localization of N-RAP at the Interface between Myofibrils and Intercalated Disks in the Mouse Heart (2001 · Biochemistry · 被引 53)
• Genomic organization, alternative splicing, and expression of human and mouse N‐RAP , a nebulin‐related LIM protein of striated muscle (2003 · Cell Motility and the Cytoskeleton · 被引 39)